Which cardiac biomarker is most commonly associated with evidence of a heart attack?

Which cardiac biomarker is most commonly associated with evidence of a heart attack?

• A. Myoglobin
• B. Creatine kinase
• C. Troponin T
• D. Lactate dehydrogenase

Answer: (C)

Troponin T is the correct answer as it is the cardiac biomarker most specifically associated with evidence of a heart attack. Troponins, which include Troponin T, Troponin I, and Troponin C, are proteins released into the bloodstream when the heart muscle is damaged. They are highly sensitive and specific indicators of cardiac injury, particularly myocardial infarction (heart attack). Measuring troponin levels helps clinicians diagnose and assess the severity of heart attacks, as their rise and fall can indicate the timing and extent of cardiac damage. Troponin T becomes detectable in the blood within a few hours of myocardial injury and can remain elevated for several days, making it a reliable marker for assessing recent heart attacks. This ability to differentiate between cardiac and non-cardiac conditions, as well as the timing of elevation, is what makes it the most useful biomarker in clinical practice for diagnosing heart attacks.

Troponin T is the correct answer as it is the cardiac biomarker most specifically associated with evidence of a heart attack. Troponins, which include Troponin T, Troponin I, and Troponin C, are proteins released into the bloodstream when the heart muscle is damaged. They are highly sensitive and specific indicators of cardiac injury, particularly myocardial infarction (heart attack). Measuring troponin levels helps clinicians diagnose and assess the severity of heart attacks, as their rise and fall can indicate the timing and extent of cardiac damage.

Troponin T becomes detectable in the blood within a few hours of myocardial injury and can remain elevated for several days, making it a reliable marker for assessing recent heart attacks. This ability to differentiate between cardiac and non-cardiac conditions, as well as the timing of elevation, is what makes it the most useful biomarker in clinical practice for diagnosing heart attacks.